1-9 of 9
Andrew W Greaves
Close
Sort by
Journal Articles

Validation of ZAP-70 methylation and its relative significance in predicting outcome in chronic lymphocytic leukemia

Clinical Trials & Observations
Rainer Claus, David M. Lucas, Amy S. Ruppert, Katie E. Williams, Daniel Weng, Kara Patterson, Manuela Zucknick, Christopher C. Oakes, Laura Z. Rassenti, Andrew W. Greaves, Susan Geyer, William G. Wierda, Jennifer R. Brown, John G. Gribben, Jacqueline C. Barrientos, Kanti R. Rai, Neil E. Kay, Thomas J. Kipps, Peter Shields, Weiqiang Zhao, Michael R. Grever, Christoph Plass, John C. Byrd
Journal: Blood
Blood (2014) 124 (1): 42–48.
https://doi.org/10.1182/blood-2014-02-555722
Published: 2014
Includes: Supplemental data
Journal Articles

Validation of CLL FISH Panel Scoring by Members of the Chronic Lymphocytic Leukemia Research Consortium.

Stephanie A. Smoley, Daniel L. Van Dyke, Neil E. Kay, Nyla A. Heerema, Marie L. dell’ Aquila, Prasad Koduru, Paola Dal Cin, Laura Rassenti, John C. Byrd, Kanti R. Rai, Jennifer R. Brown, Andrew W Greaves, Thomas J. Kipps, Gordon W. Dewald
Journal: Blood
Blood (2008) 112 (11): 1067.
https://doi.org/10.1182/blood.V112.11.1067.1067
Published: 2008
Journal Articles

Plasma Alemtuzumab Levels at End of Treatment Correlate with Response and Response Duration in Patients with CLL Receiving Treatment for Residual Disease.

William G Wierda, MD, PhD, Thomas J Kipps, MD, PhD, Michael J Keating, MBBS, Jennifer R Brown, MD, PhD, John G Gribben, MD, DSc, Laura Z Rassenti, PhD, Andrew W Greaves, Donna Neuberg, ScD, Susan M O’Brien, MD
Journal: Blood
Blood (2008) 112 (11): 2109.
https://doi.org/10.1182/blood.V112.11.2109.2109
Published: 2008
Journal Articles

Relative value of ZAP-70, CD38, and immunoglobulin mutation status in predicting aggressive disease in chronic lymphocytic leukemia

Laura Z. Rassenti, Sonia Jain, Michael J. Keating, William G. Wierda, Michael R. Grever, John C. Byrd, Neil E. Kay, Jennifer R. Brown, John G. Gribben, Donna S. Neuberg, Feng He, Andrew W. Greaves, Kanti R. Rai, Thomas J. Kipps
Journal: Blood
Blood (2008) 112 (5): 1923–1930.
https://doi.org/10.1182/blood-2007-05-092882
Published: 2008
Includes: Supplemental data
Journal Articles

Use of IGHV3–21 in chronic lymphocytic leukemia is associated with high-risk disease and reflects antigen-driven, post–germinal center leukemogenic selection

Emanuela M. Ghia, Sonia Jain, George F. Widhopf, II, Laura Z. Rassenti, Michael J. Keating, William G. Wierda, John G. Gribben, Jennifer R. Brown, Kanti R. Rai, John C. Byrd, Neil E. Kay, Andrew W. Greaves, Thomas J. Kipps
Journal: Blood
Blood (2008) 111 (10): 5101–5108.
https://doi.org/10.1182/blood-2007-12-130229
Published: 2008
Includes: Supplemental data
Journal Articles

KDE Analysis in Chronic Lymphocytic Leukemia Patients with B Cells Expressing IGHV3-21 and Discordant Mutational Status between Heavy and Light Chain.

Emanuela M. Ghia, PhD, Laura Z. Rassenti, PhD, George F. Widhopf, PhD, Gregg J. Silverman, MD, Andrew W. Greaves, BS, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1127.
https://doi.org/10.1182/blood.V110.11.1127.1127
Published: 2007
Journal Articles

Stereotypic IGHV3-21/IGLV3-21 Antibodies Expressed in High-Risk Chronic Lymphocytic Leukemia Bind Peptostreptococcus Magnus Protein L.

Emanuela M. Ghia, PhD, Laura Z. Rassenti, PhD, George F. Widhopf, PhD, Gregg J. Silverman, MD, Donna S. Neuberg, PhD, Michael J. Keating, MD, William G. Wierda, MD, PhD, John G. Gribben, MD, Jennifer R. Brown, MD, PhD, Kanti R. Rai, MD, John C. Byrd, MD, Neil E. Kay, MD, Andrew W. Greaves, BS, Thomas J. Kipps, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 740.
https://doi.org/10.1182/blood.V110.11.740.740
Published: 2007
Journal Articles

Study of VH3-21 in a Large Cohort of Chronic Lymphocytic Leukemia Patients Reveals Evidence for Antigen Selection and Confirms Its Predictive Value for Early Disease Progression.

Emanuela M. Ghia, PhD, Laura Z. Rassenti, Ph.D., George F. Widhopf, Ph.D., Donna S. Neuberg, Ph.D., Michael J. Keating, M.D., William G. Wierda, M.D., Ph.D., John G. Gribben, M.D., Jennifer R. Brown, M.D., Ph.D., Ian W. Flinn, M.D., Ph.D., Kanti R. Rai, M.D., John C. Byrd, M.D., Neil E. Kay, M.D., Andrew W. Greaves, B.S., Thomas J. Kipps, M.D.,Ph.D.
Journal: Blood
Blood (2006) 108 (11): 2774.
https://doi.org/10.1182/blood.V108.11.2774.2774
Published: 2006
Journal Articles

Relative Value of CD38 and ZAP-70 Versus Immunoglobulin Mutation Status in Predicting Early Disease Progression in Chronic Lymphocytic Leukemia.

Laura Z. Rassenti, PhD, Donna S. Neuberg, PhD, Lang Huynh, B.S., William G. Wierda, MD,PhD, John G. Gribben, MD, Jennifer R. Brown, MD,PhD, Ian W. Flinn, MD,PhD, Kanti R. Rai, MD, John C. Byrd, MD, Neil E. Kay, MD, Andrew W. Greaves, B.S., Thomas J. Kipps, MD,PhD
Journal: Blood
Blood (2006) 108 (11): 2778.
https://doi.org/10.1182/blood.V108.11.2778.2778
Published: 2006